Merck Appeals $26M Jury Verdict In First Vioxx Case

Law360, New York (September 22, 2006, 12:00 AM EDT) -- Merck & Co. said on Thursday that it is appealing the first jury verdict in the series of trials over the painkiller Vioxx. The plaintiff in the case won a $253 million award, later reduced to $26.1 million because of Texas caps on punitive damages.

“Among several independent grounds for reversal, the company will argue that there was insufficient evidence that Mr. Ernst suffered an injury due to Vioxx and that it was improper to allow testimony by a previously undisclosed witness midway through the trial,”...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.